Concepedia
Statistics
Publications
36
Citations
2.5K
H-Index
24
Active since
1988
Affiliations
Amgen (United States)(Current)
University of California, Santa Barbara
Merck & Co., Inc., Rahway, NJ, USA (United States)
Max-Planck-Institut für Kohlenforschung
Philipps University of Marburg
Frank Kayser is an author at Amgen (United States) specializing in drug discovery, pharmacology, and medicinal chemistry.
Publications per year
1988–2019
Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development
Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +7
Structure-Guided Design, Synthesis, and Evaluation of Guanine-Derived Inhibitors of the eIF4E mRNA–Cap Interaction
Xiaoqi Chen, David J. Kopecky, Jeff Mihalic et al. · Journal of Medicinal Chemistry · 2012 · 224 citations · Full text
Life Sciences, Medicinal Chemistry, Molecular Biology +16
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
K.R. Simonetta, Joshua P. Taygerly, Kathleen Boyle et al. · Nature Communications · 2019 · 209 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +13
Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction
Yosup Rew, Daqing Sun, Felix González-López de Turiso et al. · Journal of Medicinal Chemistry · 2012 · 169 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2
TaeWeon Lee, Ralf Schwandner, Gayathri Swaminath et al. · Molecular Pharmacology · 2008 · 155 citations
Life Sciences, Biochemistry, Pharmacology +17
1–5 of 36